A nurse is caring for a patient taking a drug that is metabolized in the liver. Additionally, the patient has been
prescribed two drugs that are both excreted from the same sites in the kidney. (Learning Objectives 1, 3, 4, and 5)
a. When the nurse is reviewing a drug to be given, the nurse notes that the drug is metabolized in the liver. What data can be gathered based on the nurse’s assessment of the patient?
b. When considering the pharmacodynamics and pharmacokinetics of a drug, what key points would the nurse tell the patient?
c. When assessing a patient for potential drug–drug interactions, what questions should the nurse ask when caring for this patient?
d. The patient is taking 20 mg of drug with a half-life of 4 hours, what amount of medication will remain 4 hours after medication administration?